A detailed history of Redpoint Investment Management Pty LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 13,096 shares of EW stock, worth $970,675. This represents 0.16% of its overall portfolio holdings.

Number of Shares
13,096
Previous 15,935 17.82%
Holding current value
$970,675
Previous $1.52 Million 28.58%
% of portfolio
0.16%
Previous 0.18%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 14, 2022

SELL
$82.37 - $107.29 $233,848 - $304,596
-2,839 Reduced 17.82%
13,096 $1.08 Million
Q1 2022

Apr 13, 2022

SELL
$101.96 - $128.34 $30,995 - $39,015
-304 Reduced 1.87%
15,935 $1.88 Million
Q4 2021

Jan 19, 2022

SELL
$106.37 - $130.68 $22,869 - $28,096
-215 Reduced 1.31%
16,239 $2.1 Million
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $9,056 - $10,802
-88 Reduced 0.53%
16,454 $1.86 Million
Q2 2021

Aug 05, 2021

SELL
$83.84 - $104.76 $36,302 - $45,361
-433 Reduced 2.55%
16,542 $1.71 Million
Q4 2020

Jan 13, 2021

SELL
$71.69 - $91.23 $24,159 - $30,744
-337 Reduced 1.95%
16,975 $1.55 Million
Q3 2020

Oct 09, 2020

SELL
$67.19 - $87.44 $1.59 Million - $2.07 Million
-23,677 Reduced 57.76%
17,312 $1.38 Million
Q2 2020

Jul 17, 2020

BUY
$57.54 - $76.95 $1.52 Million - $2.03 Million
26,393 Added 180.82%
40,989 $2.83 Million
Q1 2020

Apr 22, 2020

SELL
$52.41 - $81.0 $10,167 - $15,714
-194 Reduced 1.31%
14,596 $2.75 Million
Q4 2019

Feb 25, 2020

SELL
$71.7 - $82.09 $24,593 - $28,156
-343 Reduced 2.27%
14,790 $3.45 Million
Q3 2019

Nov 26, 2019

SELL
$61.55 - $75.43 $27,328 - $33,490
-444 Reduced 2.85%
15,133 $3.33 Million
Q4 2017

Aug 09, 2018

BUY
$33.79 - $39.39 $526,346 - $613,578
15,577
15,577 $1.76 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Redpoint Investment Management Pty LTD Portfolio

Follow Redpoint Investment Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.